133 filings
Page 4 of 7
8-K
hw2x0ol2aageuuloi
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
a3w9gtvhshqn
26 Jun 18
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
mckc hayrg7chh
3 May 18
OvaScience Reports First Quarter 2018 Financial Results and Provides Business Update
4:53pm
8-K
srt7l8tz t0eu
15 Mar 18
OvaScience Reports Fourth Quarter and Year-End 2017 Financial Results
12:00am
8-K
4cjx6
1 Feb 18
Termination of a Material Definitive Agreement
12:00am
8-K
exo5huhowm lc
8 Jan 18
Regulation FD Disclosure
12:00am
8-K
szmx4aw
3 Jan 18
OvaScienceSM Announces Corporate Update
12:00am
8-K
i4lu5x47rzsyv hs
2 Nov 17
OvaScience Reports Third Quarter 2017 Financial Results
12:00am
8-K
1p8t7j6
3 Aug 17
OvaScience Reports Second Quarter 2017 Financial Results
12:00am
8-K
s5phj4e6c015t2jb
21 Jun 17
OvaScience Appoints Christopher Kroeger, M.D., M.B.A., as Chief Executive Officer
12:00am
8-K
jswqy
14 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
d38gfy
9 May 17
OvaScience Reports First Quarter 2017 Financial Results
12:00am
8-K
ymb41kaefqrn9h xs35i
2 Mar 17
OvaScience Reports Fourth Quarter and Year-End 2016 Financial Results
12:00am
8-K
tr45pdj8n1qwg u2hj
10 Jan 17
Departure of Directors or Certain Officers
12:00am
8-K
n8fojsq
10 Jan 17
Regulation FD Disclosure
12:00am
8-K
6tkp8
23 Dec 16
OvaScience Announces Business Update
12:00am
8-K
j3n1qjo1omd2 66w
3 Nov 16
OvaScience Reports Third Quarter 2016 Financial Results
12:00am
8-K
2ss012ele3j4g
6 Sep 16
Departure of Directors or Certain Officers
12:00am
8-K
jqljyf
4 Aug 16
OvaScience Reports Second Quarter 2016 Financial Results
12:00am
8-K
12wmtg62
1 Jul 16
Departure of Directors or Certain Officers
12:00am